Blood Testing for Differential Diagnosis of Pulmonary Alveolar Proteinosis Syndrome.
作者信息
McCarthy Cormac, Carey Brenna, Trapnell Bruce C
机构信息
Translational Pulmonary Science Center, Cincinnati, OH; Division of Pulmonary Biology, Children's Hospital Medical Center, Cincinnati, OH; Division of Pulmonary Medicine, Children's Hospital Medical Center, Cincinnati, OH; Division of Pulmonary, Critical Care, and Sleep Medicine, University of Cincinnati College of Medicine, Cincinnati, OH.
Translational Pulmonary Science Center, Cincinnati, OH; Division of Pulmonary Biology, Children's Hospital Medical Center, Cincinnati, OH.
出版信息
Chest. 2019 Feb;155(2):450-452. doi: 10.1016/j.chest.2018.11.002.
Abstract
摘要
相似文献
1
Blood Testing for Differential Diagnosis of Pulmonary Alveolar Proteinosis Syndrome.用于肺泡蛋白沉积症综合征鉴别诊断的血液检测
Chest. 2019 Feb;155(2):450-452. doi: 10.1016/j.chest.2018.11.002.
2
Autoimmune Pulmonary Alveolar Proteinosis Complicated with Sarcoidosis: the Clinical Course and Serum Levels of Anti-granulocyte-macrophage colony-stimulating Factor Autoantibody.自身免疫性肺含铁血黄素沉着症并发结节病：临床经过和粒细胞-巨噬细胞集落刺激因子自身抗体的血清水平。
Intern Med. 2020 Oct 15;59(20):2539-2546. doi: 10.2169/internalmedicine.3853-19. Epub 2020 Jun 30.
3
Pulmonary alveolar proteinosis in a patient with Behcet's disease.白塞病患者并发肺泡蛋白沉积症。
Respirology. 2009 Mar;14(2):305-8. doi: 10.1111/j.1440-1843.2008.01450.x. Epub 2008 Dec 11.
4
[Pulmonary alveolar proteinosis: Analysis of 7 cases].[肺泡蛋白沉积症：7例病例分析]
Med Clin (Barc). 2016 Jun 17;146(12):e71-2. doi: 10.1016/j.medcli.2016.01.004. Epub 2016 Mar 5.
5
Bilateral peripheral infiltrates refractory to immunosuppressants were diagnosed as autoimmune pulmonary alveolar proteinosis and improved by inhalation of granulocyte/macrophage-colony stimulating factor.双侧周围性浸润对免疫抑制剂治疗无效，被诊断为自身免疫性肺泡蛋白沉积症，吸入粒细胞/巨噬细胞集落刺激因子后病情改善。
Intern Med. 2012;51(13):1737-42. doi: 10.2169/internalmedicine.51.6093. Epub 2012 Jul 1.
6
Autoantibodies against granulocyte macrophage colony-stimulating factor are diagnostic for pulmonary alveolar proteinosis.抗粒细胞巨噬细胞集落刺激因子自身抗体对肺泡蛋白沉积症具有诊断意义。
Am J Respir Cell Mol Biol. 2002 Oct;27(4):481-6. doi: 10.1165/rcmb.2002-0023OC.
7
Pulmonary alveolar proteinosis.肺泡蛋白沉积症。
Nat Rev Dis Primers. 2019 Mar 7;5(1):17. doi: 10.1038/s41572-019-0070-7.
8
Pulmonary Alveolar Proteinosis, Barbecue Smoke, and Granulocyte-macrophage Colony-stimulating Factor Therapy.肺泡蛋白沉积症、烧烤烟雾与粒细胞-巨噬细胞集落刺激因子治疗
Am J Med. 2016 Jan;129(1):e7-8. doi: 10.1016/j.amjmed.2015.08.015. Epub 2015 Sep 5.
9
Light chain (κ/λ) ratio of GM-CSF autoantibodies is associated with disease severity in autoimmune pulmonary alveolar proteinosis.GM-CSF 自身抗体的轻链（κ/λ）比值与自身免疫性肺泡蛋白沉积症的疾病严重程度相关。
Clin Immunol. 2013 Dec;149(3):357-64. doi: 10.1016/j.clim.2013.10.002. Epub 2013 Oct 11.
10
Endogenous lipoid pneumonia preceding diagnosis of pulmonary alveolar proteinosis.肺泡蛋白沉积症诊断前的内源性类脂性肺炎。
Clin Respir J. 2016 Mar;10(2):246-9. doi: 10.1111/crj.12197. Epub 2014 Sep 16.
引用本文的文献
1
Summary for clinicians: ERS guidelines on pulmonary alveolar proteinosis.临床医生摘要：欧洲呼吸学会肺泡蛋白沉积症指南。
Breathe (Sheff). 2025 May 13;21(2):240224. doi: 10.1183/20734735.0224-2024. eCollection 2025 Apr.
2
The healthcare burden of pulmonary alveolar proteinosis (PAP).肺泡蛋白沉积症（PAP）的医疗负担。
Orphanet J Rare Dis. 2025 Feb 14;20(1):73. doi: 10.1186/s13023-024-03478-2.
3
Long-term outcomes in five patients with autoimmune pulmonary alveolar proteinosis treated with molgramostim inhalation solution.五例接受莫拉司亭吸入溶液治疗的自身免疫性肺泡蛋白沉积症患者的长期预后
ERJ Open Res. 2025 Jan 27;11(1). doi: 10.1183/23120541.00567-2024. eCollection 2025 Jan.
4
A Comprehensive Outlook on Pulmonary Alveolar Proteinosis-A Review.肺肺泡蛋白沉积症的全面概述-综述。
Int J Mol Sci. 2024 Jun 28;25(13):7092. doi: 10.3390/ijms25137092.
5
Is Associated with Pulmonary Alveolar Proteinosis: A Retrospective Real-World Audit.与肺泡蛋白沉积症相关：一项回顾性真实世界审计。
Biomedicines. 2023 Oct 27;11(11):2909. doi: 10.3390/biomedicines11112909.
6
A dried blood spot test for diagnosis of autoimmune pulmonary alveolar proteinosis.一种用于诊断自身免疫性肺泡蛋白沉积症的干血斑检测方法。
J Immunol Methods. 2022 Dec;511:113366. doi: 10.1016/j.jim.2022.113366. Epub 2022 Oct 2.
7
Autoimmune Pulmonary Alveolar Proteinosis.自身免疫性肺含铁血黄素沉着症。
Am J Respir Crit Care Med. 2022 May 1;205(9):1016-1035. doi: 10.1164/rccm.202112-2742SO.
8
The Role of GM-CSF Autoantibodies in Infection and Autoimmune Pulmonary Alveolar Proteinosis: A Concise Review.粒细胞-巨噬细胞集落刺激因子自身抗体在感染和自身免疫性肺泡蛋白沉积症中的作用：简要综述
Front Immunol. 2021 Nov 22;12:752856. doi: 10.3389/fimmu.2021.752856. eCollection 2021.
9
Autoimmune pulmonary alveolar proteinosis and idiopathic pulmonary haemosiderosis: a dual pathology.自身免疫性肺肺泡蛋白沉积症和特发性肺含铁血黄素沉着症：双重病理学。
BMJ Case Rep. 2021 Apr 2;14(4):e241048. doi: 10.1136/bcr-2020-241048.
本文引用的文献
1
Prevalence and healthcare burden of pulmonary alveolar proteinosis.肺泡蛋白沉积症的患病率和医疗负担。
Orphanet J Rare Dis. 2018 Jul 31;13(1):129. doi: 10.1186/s13023-018-0846-y.
2
Standardized serum GM-CSF autoantibody testing for the routine clinical diagnosis of autoimmune pulmonary alveolar proteinosis.用于自身免疫性肺泡蛋白沉积症常规临床诊断的 GM-CSF 自身抗体标准化血清检测。
J Immunol Methods. 2014 Jan 15;402(1-2):57-70. doi: 10.1016/j.jim.2013.11.011. Epub 2013 Nov 23.
3
Characteristics of a large cohort of patients with autoimmune pulmonary alveolar proteinosis in Japan.日本一大群自身免疫性肺泡蛋白沉积症患者的特征。
Am J Respir Crit Care Med. 2008 Apr 1;177(7):752-62. doi: 10.1164/rccm.200708-1271OC. Epub 2008 Jan 17.
4
Pulmonary alveolar proteinosis.肺泡蛋白沉积症
N Engl J Med. 2003 Dec 25;349(26):2527-39. doi: 10.1056/NEJMra023226.
Zotero 插件